Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03146845 · ClinicalTrials.gov registry record · NA

Evaluation Of An Advanced Borderless Dressing

A NA study of Diabetic Foot Ulcer and Pressure Ulcer, sponsored by Smith & Nephew.

Completed
Registry status
NA
Development phase
40
Enrollment target
6
Study locations

NCT03146845 is a NA study of Diabetic Foot Ulcer and Pressure Ulcer that has completed, run by Smith & Nephew. The registered enrollment target is 40 participants, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (84% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03146845, a NA study of Diabetic Foot Ulcer and Pressure Ulcer, has completed, sponsored by Smith & Nephew.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
6
Study locations

Study Summary

This study will gather preliminary clinical, health economic, and safety data on the treatment of chronic wounds with the ALLEVYN Life Non-Bordered dressing compared to standard of care treatment when used on a wound.

Interventions

  • DEVICE ALLEVYN Life Non-Bordered
  • DEVICE Standard Care

Study Locations (6)

California

  • Center for Clinical Research - Martinez
  • UCLA Medical Center - Sylmar

Arizona

  • Titan Clinical Solutions - Phoenix

Louisiana

  • Grace Research Ltd. - Shreveport

Missouri

  • Wound Care Plus, LLC - Summit

Texas

  • JPS Health Network - Fort Worth

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-06-15
Est. Completion 2018-06-18
Phase NA

Sponsor

Smith & Nephew

72 total trials

What the Registry Record Tells You About NCT03146845

The ClinicalTrials.gov registry entry for NCT03146845 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (84% lower). The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which ALLEVYN Life Non-Bordered is the first listed.

NCT03146845 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Arizona, Louisiana.

Frequently Asked Questions

What is clinical trial NCT03146845 about?

NCT03146845 is a clinical study titled "Evaluation Of An Advanced Borderless Dressing". This study will gather preliminary clinical, health economic, and safety data on the treatment of chronic wounds with the ALLEVYN Life Non-Bordered dressing compared to standard of care treatment when used on a wound.

What is the current status of trial NCT03146845?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-06-15. Estimated completion is 2018-06-18.

What conditions does trial NCT03146845 study?

This clinical trial studies the following conditions: Diabetic Foot Ulcer, Pressure Ulcer, Leg Ulcer.

What interventions are being tested in trial NCT03146845?

The interventions under investigation include: ALLEVYN Life Non-Bordered (DEVICE), Standard Care (DEVICE).

Who is sponsoring clinical trial NCT03146845?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03146845 being conducted?

This trial has 6 study locations across Arizona, California, Louisiana, Missouri, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.